Clinical Trials Browser

folfirinox × Tumor-Agnostic × Clear all

NCT02178709 2022-04-19

A Phase II Study of Neoadjuvant FOLFIRINOX

Phase 2 Completed

48 enrolled 16 charts

Neoplasms

NCT04398927 2021-02-04

Systemic Chemotherapy Plus PD-1 for Metastasis ICC

Phase 2 Withdrawn

Neoplasm Metastasis